
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetic treatment of solid tumours: a review of clinical trials
Clara Nervi, Elisabetta De Marinis, Giovanni Codacci-Pisanelli
Clinical Epigenetics (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 195
Clara Nervi, Elisabetta De Marinis, Giovanni Codacci-Pisanelli
Clinical Epigenetics (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 195
Showing 1-25 of 195 citing articles:
Cancer stem cells revisited
Eduard Batlle, Hans Clevers
Nature Medicine (2017) Vol. 23, Iss. 10, pp. 1124-1134
Open Access | Times Cited: 2341
Eduard Batlle, Hans Clevers
Nature Medicine (2017) Vol. 23, Iss. 10, pp. 1124-1134
Open Access | Times Cited: 2341
3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs
Ana S. Nunes, Andreia S. Barros, Elisabete C. Costa, et al.
Biotechnology and Bioengineering (2018) Vol. 116, Iss. 1, pp. 206-226
Open Access | Times Cited: 584
Ana S. Nunes, Andreia S. Barros, Elisabete C. Costa, et al.
Biotechnology and Bioengineering (2018) Vol. 116, Iss. 1, pp. 206-226
Open Access | Times Cited: 584
Inside HDACs with more selective HDAC inhibitors
Joëlle Roche, Philìppe Bertrand
European Journal of Medicinal Chemistry (2016) Vol. 121, pp. 451-483
Closed Access | Times Cited: 294
Joëlle Roche, Philìppe Bertrand
European Journal of Medicinal Chemistry (2016) Vol. 121, pp. 451-483
Closed Access | Times Cited: 294
Immuno-Oncology: Emerging Targets and Combination Therapies
Henry T. Marshall, Mustafa B.A. Djamgoz
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 281
Henry T. Marshall, Mustafa B.A. Djamgoz
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 281
Epigenetic therapy for ovarian cancer: promise and progress
Sara Moufarrij, Monica Dandapani, Elisa Arthofer, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 278
Sara Moufarrij, Monica Dandapani, Elisa Arthofer, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 278
Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
Tathiane M. Malta, Camila Ferreira de Souza, Thaís S. Sabedot, et al.
Neuro-Oncology (2017) Vol. 20, Iss. 5, pp. 608-620
Open Access | Times Cited: 244
Tathiane M. Malta, Camila Ferreira de Souza, Thaís S. Sabedot, et al.
Neuro-Oncology (2017) Vol. 20, Iss. 5, pp. 608-620
Open Access | Times Cited: 244
Cancer cell plasticity during tumor progression, metastasis and response to therapy
Andrea Pérez-González, Kevin Bévant, Cédric Blanpain
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1063-1082
Open Access | Times Cited: 143
Andrea Pérez-González, Kevin Bévant, Cédric Blanpain
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1063-1082
Open Access | Times Cited: 143
Beyond genetics: Exploring the role of epigenetic alterations in breast cancer
Kirti S. Prabhu, Hana Q. Sadida, Shilpa Kuttikrishnan, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155174-155174
Open Access | Times Cited: 16
Kirti S. Prabhu, Hana Q. Sadida, Shilpa Kuttikrishnan, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155174-155174
Open Access | Times Cited: 16
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers
Jeannine Diesch, Anabel Zwick, Anne-Kathrin Garz, et al.
Clinical Epigenetics (2016) Vol. 8, Iss. 1
Open Access | Times Cited: 152
Jeannine Diesch, Anabel Zwick, Anne-Kathrin Garz, et al.
Clinical Epigenetics (2016) Vol. 8, Iss. 1
Open Access | Times Cited: 152
EMT‐ and MET‐related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities
Ulf D. Kahlert, Justin V. Joseph, Frank A.E. Kruyt
Molecular Oncology (2017) Vol. 11, Iss. 7, pp. 860-877
Open Access | Times Cited: 149
Ulf D. Kahlert, Justin V. Joseph, Frank A.E. Kruyt
Molecular Oncology (2017) Vol. 11, Iss. 7, pp. 860-877
Open Access | Times Cited: 149
Epigenetic control of gene expression: Potential implications for cancer treatment
Francesco Perri, Francesco Longo, M Giuliano, et al.
Critical Reviews in Oncology/Hematology (2017) Vol. 111, pp. 166-172
Closed Access | Times Cited: 144
Francesco Perri, Francesco Longo, M Giuliano, et al.
Critical Reviews in Oncology/Hematology (2017) Vol. 111, pp. 166-172
Closed Access | Times Cited: 144
Effects of ionizing radiation on DNA methylation: from experimental biology to clinical applications
Isabelle R. Miousse, Kristy Kutanzi, Igor Koturbash
International Journal of Radiation Biology (2017) Vol. 93, Iss. 5, pp. 457-469
Open Access | Times Cited: 142
Isabelle R. Miousse, Kristy Kutanzi, Igor Koturbash
International Journal of Radiation Biology (2017) Vol. 93, Iss. 5, pp. 457-469
Open Access | Times Cited: 142
How to stomach an epigenetic insult: the gastric cancer epigenome
Nisha Padmanabhan, Toshikazu Ushijima, Patrick Tan
Nature Reviews Gastroenterology & Hepatology (2017) Vol. 14, Iss. 8, pp. 467-478
Closed Access | Times Cited: 139
Nisha Padmanabhan, Toshikazu Ushijima, Patrick Tan
Nature Reviews Gastroenterology & Hepatology (2017) Vol. 14, Iss. 8, pp. 467-478
Closed Access | Times Cited: 139
Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
Barbara Pasculli, Raffaela Barbano, Paola Parrella
Seminars in Cancer Biology (2018) Vol. 51, pp. 22-35
Closed Access | Times Cited: 139
Barbara Pasculli, Raffaela Barbano, Paola Parrella
Seminars in Cancer Biology (2018) Vol. 51, pp. 22-35
Closed Access | Times Cited: 139
Dual Inhibition of DNA and Histone Methyltransferases Increases Viral Mimicry in Ovarian Cancer Cells
Minmin Liu, Stacey L. Thomas, Ashley K. DeWitt, et al.
Cancer Research (2018) Vol. 78, Iss. 20, pp. 5754-5766
Open Access | Times Cited: 106
Minmin Liu, Stacey L. Thomas, Ashley K. DeWitt, et al.
Cancer Research (2018) Vol. 78, Iss. 20, pp. 5754-5766
Open Access | Times Cited: 106
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)
Masturah Bte Mohd Abdul Rashid, Tan Boon Toh, Lissa Hooi, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 453
Closed Access | Times Cited: 105
Masturah Bte Mohd Abdul Rashid, Tan Boon Toh, Lissa Hooi, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 453
Closed Access | Times Cited: 105
Increased 5-hydroxymethylcytosine in CD4 + T cells in systemic lupus erythematosus
Ming Zhao, Jing Wang, Wei Liao, et al.
Journal of Autoimmunity (2016) Vol. 69, pp. 64-73
Closed Access | Times Cited: 98
Ming Zhao, Jing Wang, Wei Liao, et al.
Journal of Autoimmunity (2016) Vol. 69, pp. 64-73
Closed Access | Times Cited: 98
The role of cancer stem cells in the modulation of anti-tumor immune responses
Cristina Maccalli, Kakil Ibrahim Rasul, Mamoun Elawad, et al.
Seminars in Cancer Biology (2018) Vol. 53, pp. 189-200
Open Access | Times Cited: 88
Cristina Maccalli, Kakil Ibrahim Rasul, Mamoun Elawad, et al.
Seminars in Cancer Biology (2018) Vol. 53, pp. 189-200
Open Access | Times Cited: 88
DNMT Inhibitors Increase Methylation in the Cancer Genome
Anil K Giri, Tero Aittokallio
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 88
Anil K Giri, Tero Aittokallio
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 88
Cancer's epigenetic drugs: where are they in the cancer medicines?
Sorayya Ghasemi
The Pharmacogenomics Journal (2019) Vol. 20, Iss. 3, pp. 367-379
Closed Access | Times Cited: 85
Sorayya Ghasemi
The Pharmacogenomics Journal (2019) Vol. 20, Iss. 3, pp. 367-379
Closed Access | Times Cited: 85
Role of Methylation in Pro- and Anti-Cancer Immunity
Ali Mehdi, Shafaat A. Rabbani
Cancers (2021) Vol. 13, Iss. 3, pp. 545-545
Open Access | Times Cited: 80
Ali Mehdi, Shafaat A. Rabbani
Cancers (2021) Vol. 13, Iss. 3, pp. 545-545
Open Access | Times Cited: 80
Ovarian cancer: epigenetics, drug resistance, and progression
Weiwei Xie, Huizhen Sun, Xiaoduan Li, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 64
Weiwei Xie, Huizhen Sun, Xiaoduan Li, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 64
DNA Methylation: From Cancer Biology to Clinical Perspectives
Chen Chen, Zehua Wang, Yi Ding, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 12, pp. 326-326
Open Access | Times Cited: 41
Chen Chen, Zehua Wang, Yi Ding, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 12, pp. 326-326
Open Access | Times Cited: 41
Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination
Wei Zhao, Xiao‐Di Zheng, Paula Yun‐Zhi Tang, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1778-1808
Closed Access | Times Cited: 40
Wei Zhao, Xiao‐Di Zheng, Paula Yun‐Zhi Tang, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1778-1808
Closed Access | Times Cited: 40
Epigenetics in epilepsy
Katja Kobow, Ingmar Blümcke
Neuroscience Letters (2017) Vol. 667, pp. 40-46
Closed Access | Times Cited: 83
Katja Kobow, Ingmar Blümcke
Neuroscience Letters (2017) Vol. 667, pp. 40-46
Closed Access | Times Cited: 83